INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION
Food supplement declared in France, declaration No 2020-4-783
INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION, from BIOGARAN, is a food supplement declared in France. Status: withdrawn from the market on 15 June 2023. Main ingredients: Aesculus hippocastanum 480 mg per day, Ruscus aculeatus 100 mg per day, Aesculus hippocastanum 60 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- INTRAIT MARRON D'INDE
- Food business operator placing the product on the market
- BIOGARAN
- Status
- Withdrawn from the market on 15 June 2023
- Form
- Capsule
- Daily dose
- DJMR : 4 gélules / jour
- Directions for use
- 1 gélule matin et soir. Si nécessaire, doubler la prise, soit 2 gélules matin et soir.
- Not recommended (according to the manufacturer)
- Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Blood and lymphatic circulation
Declaration 168431, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Extrait sec hydroalcoolique | 480 mg |
| Ruscus aculeatus L. | Rhizome | Extrait sec hydroalcoolique | 100 mg |
| Aesculus hippocastanum L. | Ecorce | Extrait sec hydroalcoolique | 60 mg |
Additives
E460, E470b, E141, E464
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne peuvent être utilisés comme substituts d’un régime alimentaire varié et équilibré et d’un mode de vie sain. Tenir hors de portée des enfants. Déconseillé aux enfants, aux femmes enceintes et aux personnes sous traitement anti-coagulant.
Regulatory points
- Information
Withdrawn from the market on 15 June 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION INTRAIT MARRON D'INDE, declared in 2021, withdrawn from the market : same declared composition
Brand : INTRAIT MARRON D'INDE
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION: composition and regulation”, https://compoatlas.com/en/supplements/products/168431-intrait-marron-d-inde-jambes-legeres-circulation, updated 15 November 2026.